Literature DB >> 3755750

Molecular determinants of alphavirus neurovirulence: nucleotide and deduced protein sequence changes during attenuation of Venezuelan equine encephalitis virus.

B J Johnson, R M Kinney, C L Kost, D W Trent.   

Abstract

The nucleotide and deduced amino acid sequences of the structural proteins of the TC-83 vaccine strain of Venezuelan equine encephalitis (VEE) virus have been determined from a cDNA clone containing the 26S mRNA coding region. A cDNA clone encoding the equivalent region of the virulent parent VEE virus [Trinidad donkey strain (TRD)] has been sequenced previously. Comparison of the sequences of the TC-83 and TRD cDNA clones revealed 13 nucleotide differences. Neither the organization of the structural proteins (5'-capsid-E3-E2-6K-E1-3') nor the length (3762 nucleotides) of the open reading frame coding for the viral polyprotein precursor was altered during attenuation. Of the 13 nucleotide differences between the cDNA clones of TC-83 and TRD, nine occurred in the dominant population of the respective genomic RNAs from plaque-purified viruses. Six of the nine mutations were clustered in the E2 surface glycoprotein gene. All five of the nucleotide changes which produced non-conservative amino acid substitutions in the encoded proteins were located in the E2 gene. Two mutations occurred in the E1 glycoprotein gene; one was silent and the other did not alter the chemical character of the E1 protein. One nucleotide difference was found in the non-coding region immediately preceding the 5'-end of the 26S mRNA. The E2 and non-coding region mutations are candidates for the molecular determinants of VEE virus neurovirulence.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3755750     DOI: 10.1099/0022-1317-67-9-1951

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  18 in total

1.  Rapid, non-invasive imaging of alphaviral brain infection: reducing animal numbers and morbidity to identify efficacy of potential vaccines and antivirals.

Authors:  Michael Patterson; Allison Poussard; Katherine Taylor; Alexey Seregin; Jeanon Smith; Bi-Hung Peng; Aida Walker; Jenna Linde; Jennifer Smith; Milagros Salazar; Slobodan Paessler
Journal:  Vaccine       Date:  2011-10-12       Impact factor: 3.641

2.  Treatment of Venezuelan equine encephalitis virus infection with (-)-carbodine.

Authors:  Justin G Julander; Richard A Bowen; Jagadeeshwar R Rao; Craig Day; Kristiina Shafer; Donald F Smee; John D Morrey; Chung K Chu
Journal:  Antiviral Res       Date:  2008-08-15       Impact factor: 5.970

3.  Mutagenesis of the 3' nontranslated region of Sindbis virus RNA.

Authors:  R J Kuhn; Z Hong; J H Strauss
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

4.  Molecular analysis of Sindbis virus pathogenesis in neonatal mice by using virus recombinants constructed in vitro.

Authors:  J M Polo; N L Davis; C M Rice; H V Huang; R E Johnston
Journal:  J Virol       Date:  1988-06       Impact factor: 5.103

5.  Ablation of Programmed -1 Ribosomal Frameshifting in Venezuelan Equine Encephalitis Virus Results in Attenuated Neuropathogenicity.

Authors:  Joseph A Kendra; Cynthia de la Fuente; Ashwini Brahms; Caitlin Woodson; Todd M Bell; Bin Chen; Yousuf A Khan; Jonathan L Jacobs; Kylene Kehn-Hall; Jonathan D Dinman
Journal:  J Virol       Date:  2017-01-18       Impact factor: 5.103

6.  A viral RNA structural element alters host recognition of nonself RNA.

Authors:  Jennifer L Hyde; Christina L Gardner; Taishi Kimura; James P White; Gai Liu; Derek W Trobaugh; Cheng Huang; Marco Tonelli; Slobodan Paessler; Kiyoshi Takeda; William B Klimstra; Gaya K Amarasinghe; Michael S Diamond
Journal:  Science       Date:  2014-01-30       Impact factor: 47.728

7.  A mouse attenuated mutant of Junin virus with an altered envelope glycoprotein.

Authors:  L A Scolaro; S E Mersich; E B Damonte
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

Review 8.  The alphaviruses: gene expression, replication, and evolution.

Authors:  J H Strauss; E G Strauss
Journal:  Microbiol Rev       Date:  1994-09

9.  Divergent envelope E2 alphavirus sequences spanning amino acids 297 to 352 induce in mice virus-specific protective immunity and antibodies with complement-mediated cytolytic activity.

Authors:  H Grosfeld; S Lustig; Y Gozes; B Velan; S Cohen; M Leitner; B Lachmi; D Katz; U Olshevski; A Shafferman
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

10.  C3H/HeN mouse model for the evaluation of antiviral agents for the treatment of Venezuelan equine encephalitis virus infection.

Authors:  Justin G Julander; Ramona Skirpstunas; Venkatraman Siddharthan; Kristiina Shafer; Justin D Hoopes; Donald F Smee; John D Morrey
Journal:  Antiviral Res       Date:  2008-02-13       Impact factor: 5.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.